Publikationen, an denen er mitarbeitet Eduardo Arilla Ferreiro (40)

2020

  1. A nitric oxide synthase inhibitor, L-NAME, prevents L-arginine-induced downregulation of the rat cortical somatostatinergic system

    NeuroReport, Vol. 31, Núm. 2, pp. 87-91

  2. Oxidative Stress and Lymphocyte Alterations in Chronic Relapsing Experimental Allergic Encephalomyelitis in the Rat Hippocampus and Protective Effects of an Ethanolamine Phosphate Salt

    Molecular Neurobiology, Vol. 57, Núm. 2, pp. 860-878

2013

  1. Acute up-regulation of the rat brain somatostatin receptor-effector system by leptin is related to activation of insulin signaling and may counteract central leptin actions

    Neuroscience, Vol. 252, pp. 289-301

  2. Bases moleculares de la encefalomielitis autoinmune experimental crónica recidivante como modelo animal de la esclerosis múltiple

    Cuartas Jornadas de Jóvenes Investigadores de la Universidad de Alcalá: Ciencias

  3. Efecto de la queleritrina y de la ciclosporina sobre la peroxidación lipídica y receptores de somatostatina en hipocampo de rata con encefalomielitis autoinmune experimental

    Dianas: revista de dianas terapéuticas, Vol. 2, Núm. 2

  4. Vitamin E deficiency impairs the somatostatinergic receptor-effector system and leads to phosphotyrosine phosphatase overactivation and cell death in the rat hippocampus

    Journal of Nutritional Biochemistry, Vol. 24, Núm. 5, pp. 848-858

2012

  1. Leptin-induced downregulation of the rat hippocampal somatostatinergic system may potentiate its anorexigenic effects

    Neurochemistry International, Vol. 61, Núm. 8, pp. 1385-1396

  2. Metabolism and function of vitamin E

    Tocopherol: Sources, Uses and Health Benefits (Nova Science Publishers, Inc.), pp. 205-232

2011

  1. Efectos de la sal del calcio, magnesio y fosfato de etanolamina sobre el estres oxidativo en un modelo animal de esclorosis múltiple

    Terceras Jornadas de Jóvenes Investigadores de la Universidad de Alcalá

  2. Role of ethanolamine phosphate in the hippocampus of rats with acute experimental autoimmune encephalomyelitis

    Neurochemistry International, Vol. 58, Núm. 1, pp. 22-34

2009

  1. Effects of the antipsychotic drug haloperidol on the somastostatinergic system in SH-SY5Y neuroblastoma cells

    Journal of Neurochemistry, Vol. 110, Núm. 2, pp. 631-640

  2. Minocycline prevents Aβ(25-35)-induced reduction of somatostatin and neprilysin content in rat temporal cortex

    Life Sciences, Vol. 84, Núm. 7-8, pp. 205-210

  3. Sulfadiazine partially protects the rat temporal cortex from amyloid beta peptide (25-35)-induced alterations of the somatostatinergic system

    Neuroendocrinology, Vol. 89, Núm. 4, pp. 400-410

  4. α-Tocopherol decreases the somatostatin receptor-effector system and increases the cyclic AMP/cyclic AMP response element binding protein pathway in the rat dentate gyrus

    Neuroscience, Vol. 162, Núm. 1, pp. 106-117

2008

  1. Minocycline provides protection against β-amyloid(25-35)-induced alterations of the somatostatin signaling pathway in the rat temporal cortex

    Neuroscience, Vol. 154, Núm. 4, pp. 1458-1466

  2. Somatostatin and Alzheimer's disease

    Molecular and Cellular Endocrinology, Vol. 286, Núm. 1-2, pp. 104-111

2007

  1. 17β-Estradiol protects depletion of rat temporal cortex somatostatinergic system by β-amyloid

    Neurobiology of Aging, Vol. 28, Núm. 9, pp. 1396-1409

  2. Alteration of the somatostatinergic system in the striatum of rats with acute experimental autoimmune encephalomyelitis

    Neuroscience, Vol. 148, Núm. 1, pp. 238-249

  3. Chronic but not acute intracerebroventricular administration of amyloid β-peptide(25-35) decreases somatostatin content, adenylate cyclase activity, somatostatin-induced inhibition of adenylate cyclase activity, and adenylate cyclase I levels in the rat hippocampus

    Journal of Neuroscience Research, Vol. 85, Núm. 2, pp. 433-442

2006

  1. A vitamin A-free diet results in impairment of the rat hippocampal somatostatinergic system

    Neuroscience, Vol. 141, Núm. 2, pp. 851-861